Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Receivables (2020 - 2025)

Historic Receivables for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $3.0 million.

  • Biofrontera's Receivables fell 3855.15% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 3855.15%. This contributed to the annual value of $5.3 million for FY2024, which is 3324.54% down from last year.
  • Latest data reveals that Biofrontera reported Receivables of $3.0 million as of Q3 2025, which was down 3855.15% from $4.0 million recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Receivables ranged from a high of $12.4 million in Q4 2021 and a low of $2.1 million during Q3 2021
  • Its 5-year average for Receivables is $5.7 million, with a median of $5.3 million in 2024.
  • In the last 5 years, Biofrontera's Receivables soared by 27795.68% in 2021 and then crashed by 5307.65% in 2024.
  • Biofrontera's Receivables (Quarter) stood at $12.4 million in 2021, then fell by 17.56% to $10.2 million in 2022, then fell by 22.31% to $8.0 million in 2023, then crashed by 33.25% to $5.3 million in 2024, then plummeted by 43.65% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $4.0 million for Q2 2025, and $4.2 million during Q1 2025.